We detected multiple NK cell family receptor encoding genes (e.g., KLRK1, NCR2, CD2, and CD160) which might be critical in mediating anti-tumour immune responses against BLCA because higher expression of these genes was associated with better patient survival probabilities. Here, CD160 is linked to neoplasm.